Q517--New AMA Pharmacy HD Compounding Contract Amarillo VA

The Department of Veterans Affairs (VA) Veterans Health Administration, specifically VISN 17's Network Contracting Office, is seeking a pharmacy compounding contractor for the Amarillo VA Medical Center to provide hazardous sterile chemotherapy product preparation services. The contract requires a U.S.-based contractor with CETA CAG certified engineering control environments capable of delivering next-day compounded chemotherapeutic preparations based on medication orders from VA Oncologists or Hematologists. Vendors must demonstrate compliance with Joint Commission standards, VA Medical Center policies, and complete annual privacy training. The solicitation (Solicitation Number: 36C25725Q0076) is classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC Q517 (Pharmacy Services), with responses due by May 7, 2025. Performance will be evaluated using a Quality Assurance Surveillance Plan (QASP), which will document and assess contractor performance against strict standards.

The contract is not set aside for any specific small business category and represents an Indefinite-Delivery Contract with a minimum value of $20,000 and a maximum value of $240,000. The performance period will run from June 1, 2025, through May 31, 2026, covering pharmaceutical compounding services for the Amarillo VA Medical Center located at 6010 Amarillo Blvd. West, Amarillo, TX. Contractors must maintain 100% accountability of records, ensure timely order processing, and provide daily shift reports and monthly activity reports. The associated VA Pricing document dated June 1, 2025, includes comprehensive pricing for over 300 drug items, with provisions for monthly pricing updates. The point of contact for this opportunity is Contracting Officer Jennifer Stringer, who can be reached at jennifer.stringer@va.gov or 254-421-3957.